Treatment for adults and children for:
- Chronic myeloid leukaemia (CML): Leukaemia is a cancer of white blood cells.
- Treatment for adults for certain other types of leukaemia or cancer of the stomach and skin.
Do not take IMATINIB ACCORD:
Take special care with IMATINIB ACCORD:
If IMATINIB ACCORD is used in children, close monitoring of growth in children is recommended.
Always tell your healthcare professional if you are taking any other medicine. (This includes complementary or traditional medicines.)
Before taking IMATINIB ACCORD tell your doctor if you are using any of the following:
Do not share medicines prescribed for you with any other person. Always take IMATINIB ACCORD exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure.
Your doctor will advise you on the dose you should be taking for your specific condition.
Your doctor may adjust the dosage if necessary for any of the conditions mentioned above depending on the severity of the condition and the side effects you experience. Your doctor will tell you how long your treatment with IMATINIB ACCORD will last. Do not stop treatment early without consulting your doctor because it may decrease the effectiveness of the treatment. If you have the impression that the effect of IMATINIB ACCORD is too strong or too weak, tell your doctor or pharmacist.
If you take more IMATINIB ACCORD than you should:
In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre.
If you forget to take IMATINIB ACCORD:
If you have missed your dose by only a few hours, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take IMATINIB ACCORD at the next regularly scheduled time. Do not take a double dose to make up for forgotten individual doses.
IMATINIB ACCORD can have side effects. Not all side effects reported for IMATINIB ACCORD are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking IMATINIB ACCORD, please consult your doctor, pharmacist or other healthcare professional for advice.
If any of the following happens, stop taking IMATINIB ACCORD and tell your doctor immediately or go to the casualty department at your nearest hospital:
These are all very serious side effects. If you have them, you may have had a serious reaction to IMATINIB ACCORD. You may need urgent medical attention or hospitalisation.
Tell your doctor immediately or go to the casualty department at your nearest hospital if you notice any of the following:
These are all serious side effects. You may need urgent medical attention.
Tell your doctor as soon as possible if you notice any of the following:
The following side effects occur frequently:
The following side effects occur less frequently:
The following side effects may also occur:
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
If you get side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8 By reporting side effects, you can help provide more information on the safety of IMATINIB ACCORD.
Store at or below 25 °C. Protect from moisture. Keep blisters in the carton until required for use. Store all medicines out of reach of children. Do not use after the expiry date printed on the label or carton. Return all unused medicine to your pharmacist.
The Imatinib Accord Film-Coated Tablets professional information leaflet below is the property of Accord Healthcare and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
The patient information text is available above. Load the original PDF only when you need it.